ORIC Pharmaceuticals, Inc. (ORIC) Tops Q1 EPS by 2c

ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) reported Q1 EPS of ($0.53), $0.02 better than the analyst estimate of ($0.55).

For earnings history and earnings-related data on ORIC Pharmaceuticals, Inc. (ORIC) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• ORIC Pharmaceuticals (ORIC) PT Raised to $27 at H.C. Wainwright